Akpek et al developed a prognostic factor score (PS) for a patient with chronic graft-versus-host disease (GVHD). This can help identify a patient who may benefit from more aggressive management. The authors are from Johns Hopkins University, Fred Hutchinson Cancer Center in Seattle, University of Nebraska, University of Minnesota, and the International BMT Registry GVHD Working Group in Milwaukee.